Michael Gladstone
InvestorPartner at Atlas Venture
Boston, Massachusetts
Writes $10M – $50M checks · typically $25M
About
Michael Gladstone is a partner at Atlas Venture, which he joined in 2012, and works on forming new therapeutics companies. Before Atlas, he worked at L.E.K. Consulting on business development and corporate strategy for biopharma clients, and earlier led HIV vaccine research in the Viral Pathogenesis department at Beth Israel Deaconess Medical Center. He holds an AB in biochemical sciences from Harvard College.
Invests in
Biotech
Experience
- Atlas VenturePartnercurrent2020 — present
- Atlas VenturePrincipalcurrent2015 — presentCambridge, MA
- Atlas VentureAssociate2012 — 2014Boston
- L.E.K. ConsultingSenior Associate Consultant2009 — 2012Boston
- Eutropics PharmaceuticalsMLSC Fellow2009Boston
Education
- Harvard UniversityBA, Biochemical Sciences2005 — 2009
Same school
Also attended Harvard University1,170
+ 1,164 more
Shared employers
Also worked at Atlas Venture51
+ 45 more
Also worked at L.E.K. Consulting117
.jpg)
+ 111 more
Deals · 2
Caldera Therapeutics, Inc.Board seat
via Atlas Venture · filed Jan 2026 · $37.5M raise
Day One Biopharmaceuticals Holding Co LLCBoard seat
via Atlas Venture · filed Feb 2021 · $130M raise
Attribution from SEC filings, press coverage, and firm rosters.
